Department of Neuroscience & Cell Biology, University of Texas Medical Branch at Galveston, Texas, 77555-1043, USA.
Curr Neuropharmacol. 2011 Dec;9(4):685-92. doi: 10.2174/157015911798376316.
Alzheimer's disease (AD) is an incurable age-related neurodegenerative disorder characterized by profound memory dysfunction. This bellwether symptom suggests involvement of the hippocampus -- a brain region responsible for memory formation -- and coincidentally an area heavily burdened by hyperphosphorylated tau and neuritic plaques of amyloid beta (Aβ). Recent evidence suggests that pre-fibrillar soluble Aβ underlies an early, progressive loss of synapses that is a hallmark of AD. One of the downstream effects of soluble Aβ aggregates is the activation of the phosphatase calcineurin (CaN). This review details the evidence of CaN hyperactivity in 'normal' aging, models of AD, and actual disease pathogenesis; elaborates on how this could manifest as memory impairment, neuroinflammation, hyperphosphorylated tau, and neuronal death.
阿尔茨海默病(AD)是一种不可治愈的与年龄相关的神经退行性疾病,其特征是严重的记忆功能障碍。这一先驱症状提示涉及海马体——负责记忆形成的大脑区域——巧合的是,海马体也受到高度磷酸化的tau 和淀粉样β(Aβ)的神经突斑块的影响。最近的证据表明,原纤维可溶性 Aβ是突触进行性丧失的早期基础,这是 AD 的标志。可溶性 Aβ 聚集物的下游效应之一是磷酸酶钙调神经磷酸酶(CaN)的激活。这篇综述详细说明了 CaN 活性过度在“正常”衰老、AD 模型和实际疾病发病机制中的证据;阐述了这如何表现为记忆障碍、神经炎症、过度磷酸化的 tau 和神经元死亡。